Journal of Autism and Developmental Disorders
40(10), pp. 1209-1218.
Lindsay R. L. et al. (2006)
Journal of Intellectual and Developmental Disability
December, 31(4), pp. 204-209.
Challenges in evaluating psychosocial interventions for autistic spectrum disorders.
Journal of Autism and Developmental Disorders
35(6), pp. 695-708
Journal of Autism and Developmental Disorders
33(1), pp. 77-85
Open-label quetiapine in the treatment of children and adolescents with autistic disorder.
Journal of Child and Adolescent Psychopharmacology
9(2), pp. 99-107
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
American Journal of Psychiatry
161(6), pp. 1125-1127
Mazefsky C. A. et al. (2013)
The role of emotion regulation in autism spectrum disorder.
Journal of the American Academy of Child and Adolescent Psychiatry
52(7), pp. 679-688.
McCracken J. T. et al. (2002)
Risperidone in children with autism and serious behavioral problems.
New England Journal of Medicine
347(5), pp. 314-321
McDougle C. J. et al. (2000)
Child and Adolescent Psychiatric Clinics of North America
January, 9(1), pp. 201-224.
Scahill L. et al. (2006)
A prospective open trial of guanfacine in children with pervasive developmental disorders.
Journal of Child and Adolescent Psychopharmacology
16(5), pp. 589-598.
Diagnosis and evaluation of pervasive developmental disorders.
Journal of Clinical Psychiatry
66 pp. 19-25
Scahill L. et al. (2016)
Journal of the American Academy of Child and Adolescent Psychiatry
July, 55(7), pp. 602-609.
Scahill L. et al. (2012)
Journal of the American Academy of Child and Adolescent Psychiatry
51(2), pp. 136-146
Scahill L. et al. (2001)
Journal of Child and Adolescent Psychopharmacology
Winter, 11(4), pp, 377-88.